2020 Filings While there was a more than 20 percent decline in the number of securities class actions filed in 2020 (approximately 330 cases) as compared to 2019 (approximately 430 cases), the percentage of cases filed...more
2019 Filings -
In 2019, the number of securities class action cases filed against life sciences companies reached record levels. According to Cornerstone Research, lawsuits against pharmaceutical companies increased by 40...more
4/30/2020
/ Anti-Corruption ,
Anticompetitive Behavior ,
Biotechnology ,
Class Action ,
Clinical Trials ,
Department of Justice (DOJ) ,
FDA Approval ,
Food and Drug Administration (FDA) ,
Life Sciences ,
Pharmaceutical Industry ,
Securities and Exchange Commission (SEC) ,
Securities Fraud